Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights. [PDF]
López-Castro R +6 more
europepmc +1 more source
Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]
Zahid A +8 more
europepmc +1 more source
Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. [PDF]
Cerbone L +10 more
europepmc +1 more source
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. [PDF]
Carosio R +13 more
europepmc +1 more source
Mesothelioma and Social Security Benefits in Brazil: 2019 to 2021. [PDF]
Gomes LEFE, Souza NSS.
europepmc +1 more source
Peritoneal Mesothelioma in a Patient with Long-Standing Crohn's Disease: Cause or Coincidence? [PDF]
Prata R +5 more
europepmc +1 more source
Mesotelioma pleural y exposición ambiental al amianto
La paraula amiant s'aplica a una família de silicats fibrosos i inclou tres varietats principals: el crisotil·lè, la crocidolita i l'amosita. Totes les varietats d'amiant són carcinogèniques i poden produir càncer del pulmó i mesotelioma. El mesotelioma maligne és un tumor poc freqüent que es localitza sobre tot a la pleura. Té un pronòstic molt dolent,
openaire +1 more source
A comprehensive multidisciplinary approach for identifying asbestos exposure among underground workers. [PDF]
Salvado A +5 more
europepmc +1 more source
SMO mutations confer poor prognosis in malignant pleural mesothelioma. [PDF]
Signorelli D +19 more
europepmc +1 more source
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. [PDF]
Guazzelli A +6 more
europepmc +1 more source

